Vitamin B6, magnesium, and combined B6-Mg: Therapeutic effects in childhood autism

This article reports the behavioral, biochemical, and electrophysiological effects of four therapeutic crossed-sequential double-blind trials with 60 autistic children: Trial A--vitamin B6 plus magnesium/magnesium; Trial B--vitamin B6 plus magnesium; Trial C--magnesium; and Trial D--vitamin B6. Therapeutic effects were controlled using behavior rating scales, urinary excretion of homovanillic acid (HVA), and evoked potential (EP) recordings. The behavioral improvement observed with the combination vitamin B6-magnesium was associated with significant modifications of both biochemical and electrophysiological parameters: the urinary HVA excretion decreased, and EP amplitude and morphology seemed to be normalized. These changes were not observed when either vitamin B6 or magnesium was administered alone.

[1]  M. Coleman,et al.  The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children. , 1975, Pediatrics.

[2]  Small Jg,et al.  Experiences with response averaging in autistic children. , 1969 .

[3]  L. von Knorring,et al.  Augmenting/reducing: an adaptive switch mechanism to cope with incoming signals in healthy subjects and psychiatric patients. , 1978, Neuropsychobiology.

[4]  I. van der Veen,et al.  Fluorometric determination of homovanillic acid in biological material after isolation on Sephadex G-10. , 1971, Analytical biochemistry.

[5]  E. Callaway,et al.  Effects of pyridoxine and magnesium on autistic symptoms—Initial observations , 1981, Journal of autism and developmental disorders.

[6]  B. Saletu,et al.  Fluphenazine treatment in the psychotic child: clinical-evoked potential correlations. , 1975, Comprehensive psychiatry.

[7]  E. Callaway,et al.  The effect of high doses of vitamin B6 on autistic children: a double-blind crossover study. , 1978, The American journal of psychiatry.

[8]  E. Callaway,et al.  Effects of vitamin B6 on averaged evoked potentials in infantile autism. , 1981, Biological psychiatry.

[9]  E. Callaway,et al.  Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children. , 1982, Acta vitaminologica et enzymologica.

[10]  I. Kopin,et al.  Contribution of plasma homovanillic acid (HVA) to urine and cerebrospinal fluid HVA in the monkey and its pharmacokinetic disposition. , 1978, Life sciences.

[11]  O. Franzén,et al.  Depression and somatosensory evoked potentials: I. Correlations between SEP and monoamine and purine metabolites in CSF. , 1983, Biological Psychiatry.

[12]  C. Pfeiffer,et al.  A STUDY OF ZINC DEFICIENCY AND COPPER EXCESS IN THE SCHIZOPHRENIAS , 1972 .

[13]  C. Gillberg,et al.  Childhood psychosis and monoamine metabolites in spinal fluid , 1983, Journal of autism and developmental disorders.

[14]  H. Landis,et al.  Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin. , 1980, Life sciences.

[15]  D. Cohen,et al.  Neurochemistry and child psychiatry. , 1977, Journal of the American Academy of Child Psychiatry.

[16]  R. Walter,et al.  The auditory evoked response in normal and autistic children during sleep. , 1968, Electroencephalography and clinical neurophysiology.

[17]  E. Schafer,et al.  Evidence that monoamines influence human evoked potentials , 1975, Brain Research.

[18]  M. da Prada,et al.  Magnesium-dependent ATP-ase in membranes of 5-hydroxytryptamine storage organelles. , 1972, Biochemical and biophysical research communications.

[19]  M. Coleman.  The Autistic syndromes , 1976 .

[20]  P. Voûte,et al.  Gas chromatographic determination of urinary vanilglycolic acid, vanilglycol, vanilacetic acid and vanillactic acid-chemical parameters for the diagnosis of neurogenic tumours and the evaluation of their treatment. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[21]  D. Kurtzberg,et al.  An electrophysiologic indication of auditory processing defects in autism , 1980, Psychiatry Research.

[22]  M. Coleman,et al.  A preliminary study of the effect of pyridoxine administration in a subgroup of hyperkinetic children: a double-blind crossover comparison with methylphenidate. , 1979, Biological psychiatry.

[23]  M. Jackson,et al.  Plasma zinc, copper, and amino acid levels in the blood of autistic children , 1978, Journal of autism and childhood schizophrenia.

[24]  E. Braverman,et al.  Zinc, the brain and behavior. , 1982, Biological psychiatry.

[25]  M. Lipton,et al.  Psychopharmacology : a generation of progress , 1978 .

[26]  C. Pfeiffer,et al.  20 – Copper, Zinc, Manganese, Niacin and Pyridoxine in the Schizophrenias* , 1977 .

[27]  S. Roux,et al.  Event-related potentials evoked by sensory stimulation in normal mentally retarded and autistic children. , 1980, Electroencephalography and clinical neurophysiology.

[28]  R. Brown,et al.  The effects of mefloquine on Escherichia coli. , 1979, Life sciences.

[29]  W. Bunney,et al.  Serum calcium and magnesium levels in schizophrenia. II. Possible relationship to extrapyramidal symptoms. , 1979, Archives of general psychiatry.

[30]  M. Buchsbaum,et al.  Evoked potential studies of brain catecholamine alterations in monkeys. , 1975, Journal of psychiatric research.

[31]  B. Shaywitz,et al.  Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid. , 1974, Archives of general psychiatry.